| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $57.0M | — | +444.7% |
| Cost of Revenue | $101.4M | — | +189.7% |
| Gross Profit | -$44.4M | — | -81.0% |
| R&D Expense | $10.7M | — | +56.8% |
| SG&A Expense | $24.1M | — | +14.8% |
| Operating Income | -$79.3M | — | -49.8% |
| Pre-tax Income | $508.9M | — | +3261.0% |
| Income Tax | $5K | — | +0.0% |
| Net Income | $508.9M | — | +3262.1% |
| EPS (Basic) | $2.43 | — | +478.6% |
| EPS (Diluted) | $0.12 | — | +160.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $410.7M | -27.7% | +397.5% |
| Accounts Receivable | $3.8M | -43.5% | -46.4% |
| Inventory | $58.7M | -0.5% | +45.7% |
| Current Assets | $590.0M | -16.7% | +218.0% |
| Total Assets | $799.3M | -9.7% | +203.6% |
| Current Liabilities | $125.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$119.7M | — | -314.0% |
| Capital Expenditures | $35.1M | — | +612.9% |
| Investing Cash Flow | -$35.1M | — | -614.5% |
| Financing Cash Flow | $2.7M | — | -93.7% |
| Free Cash Flow | -$154.8M | — | -357.4% |
| +38.2% |
| Long-term Debt | $619.5M | -23.8% | +90.3% |
| Total Liabilities | $1.09B | -38.4% | +56.2% |
| Stockholders' Equity | -$868.4M | +61.2% | +7.8% |